A novel deep learning prognostic system improves survival predictions for stage III non-small cell lung cancer.

In this study, a new, integrated deep learning-based prognostic model was developed and evaluated for stage III NSCLC. This novel approach may be valuable in improving patient stratification and potentially provide meaningful prognostic information that contributes to personalized therapy.